Comparison of platelet-rich plasma, bovine BMP, and rhBMP-4 on bone matrix protein expression in vitro

Growth Factors

Volumn 27, Issue 5, 2009, Pages 280-288

  Hu, Zhen Ming ^a   Peel Sean A F , S A F ^b   Ho, Stephen K C ^b   Sándor, George K B ^b   Clokie, Cameron M L ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bone marrow stromal cells; Bone matrix protein; Bone morphogenetic protein; MRNA expression; Platelet rich plasma

Indexed keywords

ALKALINE PHOSPHATASE; BONE MATRIX PROTEIN; BONE MORPHOGENETIC PROTEIN; BONE SIALOPROTEIN; COLLAGEN TYPE 1; MEMBRANE PROTEIN; MESSENGER RNA; OSTEOPONTIN; PARATHYROID HORMONE RECEPTOR; PLATELET DERIVED GROWTH FACTOR A; RECOMBINANT GROWTH FACTOR; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 4; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOASSAY; BONE DEVELOPMENT; BONE MARROW CELL; CELL DIFFERENTIATION; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEADY STATE; STROMA CELL; THROMBOCYTE RICH PLASMA; TIME;

ALKALINE PHOSPHATASE; ANIMALS; BONE MARROW CELLS; BONE MATRIX; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEINS; CATTLE; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN TYPE I; HUMANS; INTEGRIN-BINDING SIALOPROTEIN; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; OSTEOPONTIN; PLATELET-DERIVED GROWTH FACTOR; PLATELET-RICH PLASMA; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIALOGLYCOPROTEINS; STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

BOVINAE; RATTUS;

EID: 70349427140     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.1080/08977190903137819     Document Type: Article

References (38)

1. Aghaloo TL, Moy PK, Freymiller EG. 2002. Investigation of platelet-rich plasma in rabbit cranial defects: A pilot study. J Oral Maxillofac Surg 60:1176-1181.
2. Amizuka N, Karaplis AC, Henderson HE. 1996. Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development. Dev Biol 175:166-176.
3. Bautz F, Rafii S, Kanz L, Mohle R. 2000. Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells. Possible role in the hematopoietic microenvironment. Exp Hematol 28:700-706.
4. Caffesse RG, Quinones CR. 2000. Polypeptide growth factors and attachment proteins in periodontal wound healing and regeneration. Periodontology 1:69-79.
5. Camargo PM, Lekovic V,Weinlaender M, Vasilic N, Madzarevic M, Kenney EB. 2002. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. J Periodontol Res 37:300-309.
6. Chen D, Zhao M, Mundy GR. 2004. Bone morphogenetic proteins. Growth Factors 22:233-241.
7. Dai J, Rabie AB. 2007. VEGF: An essential mediator of both angiogenesis and endochondral ossification. J Dent Res 86:937-950.
8. Deckers MM, van Bezooijen RL, van der Horst G, Hoogendam J, van Der Bent C, Papapoulos SE, Lowik CW. 2002. Bone morphogenetic proteins stimulate angiogenesis through osteoblast- derived vascular endothelial growth factor A. Endocrinology 143:1545-1553.
9. Garg AK. 2000. The use of platelet-rich plasma to enhance the success of bone grafts around dental implants. Dent Implant Update 11:17-20.
10. Gordon JA, Tye CE, Sampaio AV, Underhill TM, Hunter GK, Goldberg HA. 2007. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro. Bone 41:462-473.
11. Hu Z-M, Peel SA, Sandor GK, Clokie CM. 2004. The osteoinductive activity of bone morphogenetic protein (BMP) purified by repeated extracts of bovine bone. Growth Factors 22:29-33.
12. Hu Z-M, Peel SA, Ho SK, Sándor GK, Clokie CM. 2005. Role of bovine bone morphogenetic proteins in bone matrix protein and osteoblast-related gene expression during rat bone marrow stromal cell differentiation. J Craniofac Surg 16:1006-1014.
13. Hu Z-M, Peel SA, Ho SK, Sándor GK, Clokie CM. 2008. Plateletrich plasma induces mRNA expression of VEGF and PDGF in rat bone marrow stromal cells differentiation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009, 107:43-48.
14. Janssens K, ten Dijke S, Van Hul W. 2005. Transforming growth factor-beta1 to the bone. Endocr Rev 26:743-774.
15. Kowanetz M, Ferrara N. 2006. Vascular endothelial growth factor signaling pathways: Therapeutic perspective. Clin Cancer Res 12:5018-5022.
16. Kutzler MA, Solter PF, Hoffman WE, Holkmann D. 2003. Characterization and localization of alkaline phosphatase in canine seminal plasma and gonadal tissues. Theriogenology 60:299-306.
17. Lecanda F, Avioli LV, Cheng SL. 1997. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J Cell Biochem 67:386-396.
18. Lozada JL, Caplanis N, Proussaefs P, Willardsen J, Kammeyer G. 2001. Platelet-rich plasma application in sinus graft surgery: Part I background and processing techniques. J Oral Implant 27:38-42.
19. Marx RE. 2000. Platelet concentrate: A strategy for accelerating and improving bone regeneration. In: Bone Engineering, em squared incorporated, Toronto, Canada. p 447-453.
20. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgess KR. 1998. Platelet-rich plasma: Growth factor enhancement for bone graft. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:638-646.
21. Mayr-Wohlfart U, Waltenberger J, Hausser H, Kessler S, Günther KP, Dehio C, Puhl W, Brenner RE. 2002. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30:472-477.
22. Miao D, He B, Jiang Y, Kobayashi T, Sorocéanu MA, Zhao J, Su H, Tong X, Amizuka N, Gupta A, Genant HK, Kronenberg HM, Goltzman D, Karaplis AC. 2005. Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest 115:2402-2411.
23. Mulligan MS, McDuffie JE, Shanley TP, Guo RF, Sarma JV, Warner RL, Ward PA. 2000. Role of rantes in experimental cardiac allograft rejection. Exp Mol Pathol 69:167-174.
24. Nakashima M, Reddi AH. 2003. The application of bone morphogenetic proteins to dental tissue engineering. Nat Biotechnol 21:1025-1032.
25. Okuda K, Kawase T, Momose M, Murata M, Saito Y, Suzuki H, Wolff LF, Yoshie H. 2003. Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodontally related cells in vitro. J Periodontol 74:849-857.
26. Reddi AH. 2001. Bone morphogenetic proteins: From basic science to clinical applications. J Bone Joint Surg Am 83-A(Suppl 1): S1-S6.
27. Ripamonti U, Crooks J, Rueger DC. 2001. Induction of bone formation by recombinant human osteogenic protein-1 and sintered porous hydroxyapatite in adult primates. Plast Reconstr Surg 107:977-988.
28. Robiony M, Polini F, Costa F, Politi M. 2002. Osteogenesis distraction and platelet-rich plasma for bone restoration of the severely atrophic mandible: Preliminary results. J Oral Maxillofac Surg 60:630-635.
29. Simpson DA, Murphy GM, Bhaduri T, Gardiner TA, Archer DB, Stitt AW. 1999. Expression of the VEGF gene family during retinal vaso-obliteration and hypoxia. Biochem Biophys Res Commun 262:333-340.
30. Sowa H, Kaji H, Iu MF, Tsukamoto T, Sugimoto T, Chihara K. 2003. Parathyroid hormone-Smad3 axis exerts anti-apoptotic action and augments anabolic action of transforming growth factor beta in osteoblasts. J Biol Chem 278:52240-52252.
31. Spinella-Jaegle S, Roman-Roman S, Faucheu C, Dunn FW, Kawai S, Gallea S, Stiot V, Blanchet AM, Courtois B, Baron R, Rawadi G. 2001. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-b1 on osteoblast differentiation. Bone 29:323-330.
32. Steigmann M, Garg AK. 2005. A comparative study of bilateral sinus lifts performed with platelet-rich plasma alone versus alloplastic graft material reconstituted with blood. Implant Dent 14:261-266.
33. Thorn JJ, Sørensen H, Weis-Fogh U, Andersen A. 2004. Autologous fibrin glue with growth factors in reconstructive maxillofacial surgery. Int J Oral Maxillofac Surg 33:95-100.
34. Turhani D, Weissenböck M, Stein E, Wanschitz F, Ewers R. 2007. Exogenous recombinant human BMP-2 has little initial effects on human osteoblastic cells cultured on collagen type I coated/noncoated hydroxyapatite ceramic granules. J Oral Maxillofac Surg 65:485-493.
35. Urist MR, Iwata H. 1979. A solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci USA 76:1828-1832.
36. Xu L, Anderson AL, Lu Q,Wang J. 2007. Role of fibrillar structure of collagenous carrier in bone sialoprotein-mediated matrix mineralization and osteoblast differentiation. Biomaterials 28:750-761.
37. Yamaguchi A, Ishizuya T, Kintou N, Wada Y, Katagiri T, Wozney JM, Rosen V, Yoshiki S. 1996. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun 220:366-371.
38. Yeh LC, Lee JC. 2006. Co-transfection with the osteogenic protein (OP)-1 gene and the insulin-like growth factor (IGF)-I gene enhanced osteoblastic cell differentiation. Biochim Biophys Acta 1763:57-63.